[Expression of interleukin-5 and interleukin-10 and their relationship in asthma].
Luo Bl, E S Wu, Qiu Wf, Hai Zh
Abstract
Luo Bl, E S Wu, Qiu Wf, Hai Zh
Abstract
UNLABELLED: To explore the expression of interleukin-5(IL-5) and interleukin-10(IL-10) and their relationship in asthma, we measured the cells in bronchial alveolar lavage fluid(BALF) of guinea pigs, and examined the expression of IL-5 mRNA and IL-10 mRNA of bronchial tissue by reverse transcription polymerase chain reaction(RT-PCR) in control group(Group C, n = 10), asthmatic group(Group A, n = 11) and dexamethasone treatment group(Group B, n = 10). The results showed that the eosinophil(EOS) percentage and the expression of IL-5 mRNA were significantly higher in Group A[(48.64 +/- 17.8)%, (106.91 +/- 20.09)% respectively] than that in Group C[(15.10 +/- 11.48)%, (62.60 +/- 13.84)%] and Group B[(28.4 +/- 10.32)%, (75.30 +/- 10.70)%]. In contrast, the IL-10 mRNA expression in Group A[(47.5 +/- 5.3)%] was obviously lower compared with that in Group C[(101.2 +/- 4.2)%] and Group B[(80.1 +/- 8.3)%]. The correlation between the expression level of IL-5 mRNA and percentage of EOS was positive(r = 0.924, P < 0.01), whereas the IL-5 mRNA was negatively correlated with IL-10 mRNA expression(r = -0.731, P < 0.01). CONCLUSION: IL-5 and EOS might play a role in the pathogenesis of asthma, the inhibition of IL-10 mRNA expression may cause the increase of IL-5 expression in asthma. The beneficial effects of corticosteroid treatment in asthma may partly result from increasing IL-10 mRNA expression and inhibiting IL-5 mRNA expression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
UNLABELLED: To explore the expression of interleukin-5(IL-5) and interleukin-10(IL-10) and their relationship in asthma, we measured the cells in bronchial alveolar lavage fluid(BALF) of guinea pigs, and examined the expression of IL-5 mRNA and IL-10 mRNA of bronchial tissue by reverse transcription polymerase chain reaction(RT-PCR) in control group(Group C, n = 10), asthmatic group(Group A, n = 11) and dexamethasone treatment group(Group B, n = 10). The results showed that the eosinophil(EOS) percentage and the expression of IL-5 mRNA were significantly higher in Group A[(48.64 +/- 17.8)%, (106.91 +/- 20.09)% respectively] than that in Group C[(15.10 +/- 11.48)%, (62.60 +/- 13.84)%] and Group B[(28.4 +/- 10.32)%, (75.30 +/- 10.70)%]. In contrast, the IL-10 mRNA expression in Group A[(47.5 +/- 5.3)%] was obviously lower compared with that in Group C[(101.2 +/- 4.2)%] and Group B[(80.1 +/- 8.3)%]. The correlation between the expression level of IL-5 mRNA and percentage of EOS was positive(r = 0.924, P < 0.01), whereas the IL-5 mRNA was negatively correlated with IL-10 mRNA expression(r = -0.731, P < 0.01). CONCLUSION: IL-5 and EOS might play a role in the pathogenesis of asthma, the inhibition of IL-10 mRNA expression may cause the increase of IL-5 expression in asthma. The beneficial effects of corticosteroid treatment in asthma may partly result from increasing IL-10 mRNA expression and inhibiting IL-5 mRNA expression.
Key concepts: Messenger RNA, Eosinophil, Interleukin 5, Interleukin 4, Asthma, Dexamethasone, Interleukin, Pathogenesis